(Q40923293)

24 September 2017

Low-efficacy HIV vaccines: potential for community-based intervention programmes (English)

1 reference

24 September 2017

R M Anderson

1

1 reference

PubMed ID

8855867

24 September 2017

G P Garnett

series ordinal

2

1 reference

PubMed ID

8855867

24 September 2017

language of work or name

English

0 references

publication date

1 October 1996

1 reference

24 September 2017

1 reference

24 September 2017

348

1 reference

24 September 2017

9033

1 reference

24 September 2017

1010-1013

1 reference

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907100-0

7 January 2021

Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907100-0

7 January 2021

A perspective on AIDS vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907100-0

7 January 2021

The WHO and why of HIV vaccine trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907100-0

7 January 2021

Potential of community-wide chemotherapy or immunotherapy to control the spread of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907100-0

7 January 2021

Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907100-0

7 January 2021

Potential impact of low efficacy HIV-1 vaccines in populations with high rates of infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907100-0

7 January 2021

Exposure efficacy and change in contact rates in evaluating prophylactic HIV vaccines in the field

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907100-0

7 January 2021

Some statistical issues in HIV vaccine trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907100-0

7 January 2021

Imperfect vaccines and herd immunity to HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907100-0

7 January 2021

Factors controlling the spread of HIV in heterosexual communities in developing countries: patterns of mixing between different age and sexual activity classes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907100-0

7 January 2021

Decreasing HIV-1 seroprevalence in young adults in a rural Ugandan cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907100-0

7 January 2021

Acceptability of HIV vaccine trials in high-risk heterosexual cohorts in Mombasa, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2907100-0

7 January 2021

10.1016/S0140-6736(96)07100-0

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

8855867